Testosterone: What to Ask About a Claim in Florida

Florida TRT cases filed in federal court were transferred to MDL 2545 — In re: Testosterone Replacement Therapy Products Liability Litigation — in the Northern District of Illinois before Judge Matthew Kennelly in Chicago. Florida is one of the leading source states for MDL plaintiffs given its large older male population and high TRT prescription rates. The MDL was substantially resolved through settlements with AbbVie, Endo, and Auxilium, and it is no longer on the JPML's list of pending MDLs (Oct. 1, 2026 report); an attorney can say whether any route remains for a new claim.

Florida's statute of limitations for personal injury and products liability is two years under Fla. Stat. § 95.11(3)(a)–(e). Florida applies the discovery rule, tolling limitations until the plaintiff knew or should have known of the injury and its causal connection to TRT. For heart attack and stroke claims, Florida courts examine when the plaintiff received medical advice linking the event to TRT use. The 2015 FDA black-box warning and subsequent media coverage may affect constructive-knowledge arguments for cases with post-2015 diagnoses.

Florida has among the nation's highest rates of TRT prescription and cardiovascular disease, particularly in the Tampa–St. Petersburg, Miami, Orlando, and Jacksonville metro areas. Florida's large retirement-age and boomer male demographic was heavily marketed to by low-T clinic chains and concierge providers. Cardiologists throughout South Florida and the Gulf Coast region reported elevated rates of TRT-associated cardiovascular events. Florida's warm climate and active aging culture contributed to high TRT uptake among men seeking to maintain energy and vitality.

Florida plaintiffs may also assert claims under Florida's Deceptive and Unfair Trade Practices Act (FDUTPA) in addition to negligence and strict liability theories. Cases originating in Florida state courts may be removed to federal district courts (S.D. Fla., M.D. Fla., N.D. Fla.); MDL 2545 (N.D. Ill.) is no longer on the JPML's list of pending MDLs (Oct. 1, 2026 report). Florida courts are experienced with pharmaceutical mass tort litigation and have well-developed discovery protocols for medical record-intensive cases.